SECURITIES AND EXCHANGE COMMISSION 			 Washington, DC 20549 				 FORM 8-K 				 CURRENT REPORT 		 Pursuant to Section 13 or 15(d) of 		 the Securities Exchange Act of 1934 Date or Report (Date of earliest event reported): April 17, 1997 			 BIOTECHNICA INTERNATIONAL, INC. 	 (Exact name of registrant as specified in its charter) 	 Delaware 0-11854 22-2344703 (State or other jurisdiction of (Commission File (I.R.S. Employer incorporation or organization) Number) Identification No.) 4001 North War Memorial Drive, Peoria, IL 61614 	 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 309/681-0300 _____________________________________________________________ (Former name or former address, if changed since last report) ITEM 5. OTHER EVENTS FOR IMMEDIATE RELEASE: April 17, 1997 CONTACT: Bruno Carette, President and Chief Operating Officer 		Edward M. Germain, Chief Financial Officer 	 	BioTechnica International, Inc. 	 	4001 N. War Memorial Drive - Suite 200 	 	Peoria, IL 61614 	 	(309) 681-0300 BIOTECHNICA INTERNATIONAL, INC. ANNOUNCES THAT THE NASDAQ-NMS HAS DELISTED THE COMPANY'S COMMON STOCK BioTechnica International, Inc. (NASDAQ: BIOT) (the "Company") has been informed by The NASDAQ Stock Market, Inc. that the Common Stock of the Company has been de-listed by the NASDAQ National Market System effective April 17, 1997. This action of the NASDAQ Stock Market, Inc. was taken subsequent to the filing of an appeal by the Company to remain on the National Market System dated March 31, 1997. The NASDAQ Stock Market, Inc. has informed the Company that it may be eligible to trade on the OTC Bulletin Board. BioTechnica International, Inc. is an agricultural products company dedicated principally to the production and marketing of proprietary hybrid corn, soybean, alfalfa, and other field seed products throughout the Midwest Corn Belt region of the United States. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 								 BioTechnica International Inc. 							By: /s/ Edward M Germain Date: April 17, 1997 Edward M Germain 							 			Chief Financial Officer